Lars Jansen Selected Research

Lars Jansen Research Topics

9	Neoplasms (Cancer) 01/2021 - 10/2004
6	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 10/2004
6	Carcinogenesis 01/2018 - 12/2005
5	Carcinoma (Carcinomatosis) 08/2013 - 06/2002
4	Ovarian Epithelial Carcinoma 01/2021 - 11/2011
4	Uterine Cervical Dysplasia 08/2013 - 06/2002
2	Ovarian Neoplasms (Ovarian Cancer) 11/2011 - 04/2011
1	Hypoxia (Hypoxemia) 01/2017
1	Leiomyoma (Uterine Fibroids) 04/2011
1	Keratoacanthoma 12/2005
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2005
1	Papilloma (Papillomatosis) 12/2005

5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2011
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2011
2	PlatinumIBA 01/2021 - 01/2016
2	Oncogene Proteins (Oncogene Protein)IBA 01/2018 - 12/2005
2	Complementary DNA (cDNA)IBA 06/2011 - 10/2004
2	Proteins (Proteins, Gene)FDA Link 12/2005 - 06/2002
1	Messenger RNA (mRNA)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 10/2017
1	Tumor Biomarkers (Tumor Markers)IBA 09/2017
1	Circulating Tumor DNAIBA 09/2017
1	Sirolimus (Rapamycin)FDA Link 01/2017
1	Viral AntigensIBA 01/2017
1	taxaneIBA 01/2016
1	AgarIBA 08/2013
1	TetraspaninsIBA 08/2013
1	Cell Surface ReceptorsIBA 08/2013
1	ChromatinIBA 09/2012
1	Carboplatin (JM8)FDA LinkGeneric 11/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2011
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2011
1	Indicators and Reagents (Reagents)IBA 11/2011
1	BRCA1 ProteinIBA 11/2011
1	Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA 06/2011
1	N 30IBA 04/2011
1	Death-Associated Protein KinasesIBA 04/2011
1	LigandsIBA 11/2008
1	Peptides (Polypeptides)IBA 11/2008
1	Histocompatibility Antigens Class IIBA 11/2008
1	Natural Killer Cell ReceptorsIBA 11/2008
1	CarcinogensIBA 12/2005
1	AntibodiesIBA 12/2005
1	Biological ProductsIBA 10/2004

2	Drug Therapy (Chemotherapy) 01/2017 - 01/2016
1	Lymph Node Excision (Lymph Node Dissection) 01/2021